Selected research
Industry Research
HMO Infant Formula Industry Research Report 2026
Market perspective
The global HMO Infant Formula market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for HMO Infant Formula is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for HMO Infant Formula is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for HMO Infant Formula is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of HMO Infant Formula include Abbott, Mead Johnson（Reckitt）, Nestlé（Wyeth Nutrition）, Danone (Aptamil), FrieslandCampina (Friso), Biostime and Yili Group (Ausnutria Dairy), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global HMO Infant Formula market in terms of revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
HMO Infant Formula Market by Company
Abbott
Mead Johnson（Reckitt）
Nestlé（Wyeth Nutrition）
Danone (Aptamil)
FrieslandCampina (Friso)
Biostime
Yili Group (Ausnutria Dairy)
HMO Infant Formula Segment by Type
2'-Fucosyllactose (2'-FL)
Others
HMO Infant Formula Segment by Application
Online Channel
Specialty Store
Supermarket
Others
HMO Infant Formula Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HMO Infant Formula market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of HMO Infant Formula and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HMO Infant Formula.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of HMO Infant Formula manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of HMO Infant Formula by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of HMO Infant Formula in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 2'-Fucosyllactose (2'-FL)
- Others
Applications
- Online Channel
- Specialty Store
- Supermarket
- Others
Companies covered
- Abbott
- Mead Johnson（Reckitt）
- Nestlé（Wyeth Nutrition）
- Danone (Aptamil)
- FrieslandCampina (Friso)
- Biostime
- Yili Group (Ausnutria Dairy)
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global HMO Infant Formula Market Size (2021-2032)
- 2.2.2 Global HMO Infant Formula Sales (2021-2032)
- 2.2.3 Global HMO Infant Formula Market Average Price (2021-2032)
- 2.3 HMO Infant Formula by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 2'-Fucosyllactose (2'-FL)
- 2.3.3 Others
- 2.4 HMO Infant Formula by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Channel
- 2.4.3 Specialty Store
- 2.4.4 Supermarket
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global HMO Infant Formula Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global HMO Infant Formula Sales (t) of Manufacturers (2021-2026)
- 3.3 Global HMO Infant Formula Revenue of Manufacturers (2021-2026)
- 3.4 Global HMO Infant Formula Average Price by Manufacturers (2021-2026)
- 3.5 Global HMO Infant Formula Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of HMO Infant Formula, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of HMO Infant Formula, Product Type & Application
- 3.8 Global Manufacturers of HMO Infant Formula, Established Date
- 3.9 Global HMO Infant Formula Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Abbott
- 4.1.1 Abbott Company Information
- 4.1.2 Abbott Business Overview
- 4.1.3 Abbott HMO Infant Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Abbott HMO Infant Formula Product Portfolio
- 4.1.5 Abbott Recent Developments
- 4.2 Mead Johnson（Reckitt）
- 4.2.1 Mead Johnson（Reckitt） Company Information
- 4.2.2 Mead Johnson（Reckitt） Business Overview
- 4.2.3 Mead Johnson（Reckitt） HMO Infant Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Mead Johnson（Reckitt） HMO Infant Formula Product Portfolio
- 4.2.5 Mead Johnson（Reckitt） Recent Developments
- 4.3 Nestlé（Wyeth Nutrition）
- 4.3.1 Nestlé（Wyeth Nutrition） Company Information
- 4.3.2 Nestlé（Wyeth Nutrition） Business Overview
- 4.3.3 Nestlé（Wyeth Nutrition） HMO Infant Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Nestlé（Wyeth Nutrition） HMO Infant Formula Product Portfolio
- 4.3.5 Nestlé（Wyeth Nutrition） Recent Developments
- 4.4 Danone (Aptamil)
- 4.4.1 Danone (Aptamil) Company Information
- 4.4.2 Danone (Aptamil) Business Overview
- 4.4.3 Danone (Aptamil) HMO Infant Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Danone (Aptamil) HMO Infant Formula Product Portfolio
- 4.4.5 Danone (Aptamil) Recent Developments
- 4.5 FrieslandCampina (Friso)
- 4.5.1 FrieslandCampina (Friso) Company Information
- 4.5.2 FrieslandCampina (Friso) Business Overview
- 4.5.3 FrieslandCampina (Friso) HMO Infant Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 FrieslandCampina (Friso) HMO Infant Formula Product Portfolio
- 4.5.5 FrieslandCampina (Friso) Recent Developments
- 4.6 Biostime
- 4.6.1 Biostime Company Information
- 4.6.2 Biostime Business Overview
- 4.6.3 Biostime HMO Infant Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Biostime HMO Infant Formula Product Portfolio
- 4.6.5 Biostime Recent Developments
- 4.7 Yili Group (Ausnutria Dairy)
- 4.7.1 Yili Group (Ausnutria Dairy) Company Information
- 4.7.2 Yili Group (Ausnutria Dairy) Business Overview
- 4.7.3 Yili Group (Ausnutria Dairy) HMO Infant Formula Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Yili Group (Ausnutria Dairy) HMO Infant Formula Product Portfolio
- 4.7.5 Yili Group (Ausnutria Dairy) Recent Developments
5 Global HMO Infant Formula Market Scenario by Region
- 5.1 Global HMO Infant Formula Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global HMO Infant Formula Sales by Region: 2021-2032
- 5.2.1 Global HMO Infant Formula Sales by Region: 2021-2026
- 5.2.2 Global HMO Infant Formula Sales by Region: 2027-2032
- 5.3 Global HMO Infant Formula Revenue by Region: 2021-2032
- 5.3.1 Global HMO Infant Formula Revenue by Region: 2021-2026
- 5.3.2 Global HMO Infant Formula Revenue by Region: 2027-2032
- 5.4 North America HMO Infant Formula Market Facts & Figures by Country
- 5.4.1 North America HMO Infant Formula Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America HMO Infant Formula Sales by Country (2021-2032)
- 5.4.3 North America HMO Infant Formula Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe HMO Infant Formula Market Facts & Figures by Country
- 5.5.1 Europe HMO Infant Formula Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe HMO Infant Formula Sales by Country (2021-2032)
- 5.5.3 Europe HMO Infant Formula Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific HMO Infant Formula Market Facts & Figures by Country
- 5.6.1 Asia Pacific HMO Infant Formula Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific HMO Infant Formula Sales by Country (2021-2032)
- 5.6.3 Asia Pacific HMO Infant Formula Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America HMO Infant Formula Market Facts & Figures by Country
- 5.7.1 South America HMO Infant Formula Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America HMO Infant Formula Sales by Country (2021-2032)
- 5.7.3 South America HMO Infant Formula Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa HMO Infant Formula Market Facts & Figures by Country
- 5.8.1 Middle East and Africa HMO Infant Formula Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa HMO Infant Formula Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa HMO Infant Formula Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global HMO Infant Formula Sales by Type (2021-2032)
- 6.1.1 Global HMO Infant Formula Sales by Type (2021-2032) & (t)
- 6.1.2 Global HMO Infant Formula Sales Market Share by Type (2021-2032)
- 6.2 Global HMO Infant Formula Revenue by Type (2021-2032)
- 6.2.1 Global HMO Infant Formula Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global HMO Infant Formula Revenue Market Share by Type (2021-2032)
- 6.3 Global HMO Infant Formula Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global HMO Infant Formula Sales by Application (2021-2032)
- 7.1.1 Global HMO Infant Formula Sales by Application (2021-2032) & (t)
- 7.1.2 Global HMO Infant Formula Sales Market Share by Application (2021-2032)
- 7.2 Global HMO Infant Formula Revenue by Application (2021-2032)
- 7.2.1 Global HMO Infant Formula Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global HMO Infant Formula Revenue Market Share by Application (2021-2032)
- 7.3 Global HMO Infant Formula Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 HMO Infant Formula Value Chain Analysis
- 8.1.1 HMO Infant Formula Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 HMO Infant Formula Production Mode & Process
- 8.2 HMO Infant Formula Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 HMO Infant Formula Distributors
- 8.2.3 HMO Infant Formula Customers
9 Global HMO Infant Formula Analyzing Market Dynamics
- 9.1 HMO Infant Formula Industry Trends
- 9.2 HMO Infant Formula Industry Drivers
- 9.3 HMO Infant Formula Industry Opportunities and Challenges
- 9.4 HMO Infant Formula Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst